Dengue is raging in Brazil. A promising local vaccine is at least a year away
When dengue started to circulate in his small town in the state of Rio Grande do Sul in Brazil, Fabio Vilella’s first thought was that he should get his 13-year-old son vaccinated. Children are especially vulnerable, and his son had dengue before, which increases the risk of severe disease. But Vilella, an environmental biologist, soon made a startling discovery: Not a single private clinic or pharmacy in the country had any vaccine left. “I’m really worried,” he says. Brazil is seeing an unprecedented surge in dengue, a viral disease that can cause excruciating pains and is sometimes fatal. An unusually hot ...
Source: ScienceNOW - March 5, 2024 Category: Science Source Type: news

ACIP: Chikungunya Vaccine Recommended for Some Travelers, Lab Workers
(MedPage Today) -- Adults should get the chikungunya vaccine (Ixchiq) if they are traveling to a country or territory where there is an outbreak of the mosquito-borne viral illness, according to a unanimous vote by the CDC's Advisory Committee... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 29, 2024 Category: American Health Source Type: news

Warning that THREE tropical diseases are heading to Britain: Health officials predict mosquito-borne illnesses like dengue will become domestic issues by 2040 because of climate change
Asian tiger mosquitoes, which spread dengue, zika and chikungunya, could become established in England by mid-century. (Source: the Mail online | Health)
Source: the Mail online | Health - December 11, 2023 Category: Consumer Health News Source Type: news

Vaccine Partner Valneva receives FDA approval for the World's first chikungunya vaccine using Albumedix' Recombumin(R)
Albumedix Ltd ('Albumedix'), now part of the life science group Sartorius, announces that Recombumin® is critical to the manufacture of the first FDA- licensed chikungunya vaccine. Valneva's lyophilized chikungunya vaccine IXCHIQ® is the first i... Biopharmaceuticals, FDA Albumedix, Sartorius, Valneva, Recombumin, chikungunya, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 22, 2023 Category: Pharmaceuticals Source Type: news

Was This a Recurrence of Non-Hodgkin ’s Lymphoma or Something Else?
“Go to the emergency room,” the doctor told him after hearing of his trip and fever, rash and whole-body weakness. “You need to be seen.” (Source: NYT Health)
Source: NYT Health - November 20, 2023 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Chikungunya Virus Non-Hodgkin ' s Lymphoma Lyme Disease Joints (Body Part) Source Type: news

Vaccine Against Chikungunya Approved By The FDA. Should You Get It?
The Food and Drug Administration recently approved a vaccine against chikungunya (pronounced chi-kuhn-goo-nyuh), a virus spread by mosquitoes in tropical areas across ... (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 20, 2023 Category: Pharmaceuticals Authors: Mark Kortepeter, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news

FDA Approves First Vaccine for Chikungunya Virus, Ixchiq
MONDAY, Nov. 13, 2023 -- The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. Food and Drug Administration on Thursday. The single-dose shot, known as Ixchiq, is approved for adults who have an increased risk... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2023 Category: Pharmaceuticals Source Type: news

World's First Chikungunya Vaccine Approved by FDA World's First Chikungunya Vaccine Approved by FDA
The mosquito-borne virus has emerged as a global threat, with a new vaccine evaluated in two large clinical trials in North America. The new shot is a single-dose injection to the muscle.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - November 11, 2023 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

FDA approves first vaccine against mosquito-borne virus chikungunya
The single-dose shot, called Ixchiq, is designed to prevent an illness that can cause debilitating joint pain for months to years. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 10, 2023 Category: Consumer Health News Authors: Sabrina Malhi Source Type: news

FDA Approves Ixchiq (Chikungunya Vaccine, Live) for the Prevention of Disease Caused by Chikungunya Virus
Saint-Herblain (France), November 10, 2023– Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Administration (FDA) has approved Ixchiq®, Valneva’s single-dose,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 10, 2023 Category: Drugs & Pharmacology Source Type: news

FDA Approves First Vaccine for Chikungunya Virus, Ixchiq
FRIDAY, Nov. 10, 2023 (Healthday News) -- The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. Food and Drug Administration on Thursday. The single-dose shot, known as Ixchiq, is approved for adults who are at... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 10, 2023 Category: General Medicine Source Type: news

First Chikungunya Vaccine Now FDA Approved — What To Know About The ‘Emerging Global Health Threat’
Experts warn the mosquito-borne virus, which can cause debilitating pain and be fatal to newborns, could become more common in the U.S. as climate change allows the insects to spread. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 10, 2023 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news

First Chikungunya Vaccine Lands Conditional FDA Approval
(MedPage Today) -- The FDA on Thursday granted accelerated approval to the first-ever chikungunya vaccine (Ixchiq) for adults at increased risk of exposure to the mosquito-transmitted virus, with confirmation of clinical benefit required for a... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 10, 2023 Category: American Health Source Type: news

A chikungunya vaccine is nearing approval. Who will get it?
The first vaccine against the mosquito-borne viral disease chikungunya will likely come to market next month. With the debilitating disease now afflicting more than half the countries in the world and threatening to spread further, the imminent U.S. Food and Drug Administration (FDA) approval of the vaccine is “great news,” says Scott Weaver, a virologist at the University of Texas Medical Branch whose own lab started to work on a chikungunya vaccine nearly 2 decades ago. The vaccine, made by the French company Valneva, will likely be recommended mainly to U.S. travelers at first. But many expect an FDA approval ...
Source: ScienceNOW - October 30, 2023 Category: Science Source Type: news

This new malaria vaccine will transform our battle with the deadliest creatures on Earth | Devi Sridhar
The breakthrough has come just in time: malaria has re-emerged in my home state of Florida, and will spread further thanks to climate changeWant to guess the most dangerous animal in the world? When my team asked children in Edinburgh during a public outreach event with schools, they said sharks, alligators, spiders and lions. All good guesses, but none on target. The deadliest animal is the mighty mosquito, which kills more than1 million people a year. Almost 700 million people contract a mosquito-borne illness each year. Mosquitoes carry serious diseases like malaria, dengue fever, West Nile virus, Zika virus and chikung...
Source: Guardian Unlimited Science - October 26, 2023 Category: Science Authors: Devi Sridhar Tags: Malaria Health World news Africa Science Source Type: news